Skip to main content

Regulatory alignment vital, says CBA

29th January 2020

Submitted by:

Andrew Warmington

The Chemical Business Association (CBA), which represents chemical distributors in the UK, has joined other associations in responding critically to Chancellor Sajid Javid’s recent statement that there would be no regulatory alignment with the EU following Brexit.

According to the CBA, it is vital for the UK’s chemical sector to have a level of regulatory alignment that preserves its frictionless access to EU markets, which account for 60% of its exports and 70% of its imports. It called on the government to negotiate a form of regulatory alignment or regulatory equivalence to this end.

“The chancellor’s remarks do not take account of the situation facing highly regulated areas of the economy, such as chemicals, that are dependent on international trade as well as underpinning the needs of UK companies.  Simply stating that the UK ‘will not be a rule-taker after Brexit’ risks denying UK business access to essential chemical products,” said CBA chief executive, Peter Newport.

“The chemical sector’s regulatory framework has a distinctive relationship with trade,” Newport added. “Regulatory compliance is the key to market access. In this case, the EU alone determines the nature and extent of the compliance required. Compliance with EU requirements is non-negotiable. Failure to comply is a barrier to market access. Without market access there can be no trade.”

According to a survey of CBA members, a “significant number” have already created subsidiaries in EU member states to ensure that they can continue to comply with EU regulation and secure market access. This has involved investing in premises and employees, where they night otherwise have invested in the UK itself. In some cases, this has meant transferring – or, in the case of EU-owned companies, repatriating – production of certain key products.

“The regulatory divergence suggested by the Chancellor pursues so far unidentified benefits but risks additional border checks and delays and costs - as the UK and EU ensure products flowing in either direction meet their respective legislative compliance requirements,” Newport said.

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

GL Chemtec has opened a new kilo lab

GL Chemtec completes kilo lab

CDMO GL Chemtec has announced the completion of a cGMP kilo lab at Oakville, Ontario

Submitted by:

Andrew Warmington

Sterling's facility at Deeside, UK

CDMOs in ADC investments

Five CDMOs across the world have separately announced investments in antibody-drug conjugates (ADCs). Piramal Pharma is

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington